Investors Research Corp’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50
Closed -$770 1037
2024
Q2
$770 Hold
50
﹤0.01% 996
2024
Q1
$739 Hold
50
﹤0.01% 974
2023
Q4
$714 Hold
50
﹤0.01% 1006
2023
Q3
$697 Hold
50
﹤0.01% 1015
2023
Q2
$589 Hold
50
﹤0.01% 1025
2023
Q1
$575 Hold
50
﹤0.01% 1062
2022
Q4
$622 Hold
50
﹤0.01% 1073
2022
Q3
$1K Hold
50
﹤0.01% 1052
2022
Q2
$1K Hold
50
﹤0.01% 1044
2022
Q1
$1K Hold
50
﹤0.01% 991
2021
Q4
$1K Hold
50
﹤0.01% 955
2021
Q3
$1K Hold
50
﹤0.01% 964
2021
Q2
$1K Hold
50
﹤0.01% 950
2021
Q1
$1K Hold
50
﹤0.01% 943
2020
Q4
$1K Hold
50
﹤0.01% 1044
2020
Q3
$1K Hold
50
﹤0.01% 1057
2020
Q2
$1K Hold
50
﹤0.01% 1061
2020
Q1
$1K Hold
50
﹤0.01% 1091
2019
Q4
$1K Hold
50
﹤0.01% 1089
2019
Q3
$1K Hold
50
﹤0.01% 1096
2019
Q2
$1K Hold
50
﹤0.01% 1044
2019
Q1
$1K Buy
+50
New +$947 ﹤0.01% 1011

Other funds holding SBRA

Investors Research Corp's SBRA Position: Q3 2024 in Review

Investors Research Corp sold out of Sabra Healthcare REIT (SBRA) in Q3 2024, closing a stake of 50 shares — an estimated $770 sold.

Investors Research Corp first reported a position in SBRA in Q1 2019 and held it in 22 quarters. The position peaked at $1K in Q3 2022. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

  • Investors Research Corp reported no remaining Sabra Healthcare REIT position as of Q3 2024 after selling out during the quarter.
  • Investors Research Corp sold 50 Sabra Healthcare REIT shares in Q3 2024, an estimated $770.
  • Investors Research Corp first reported a position in Sabra Healthcare REIT in Q1 2019 and held it in 22 quarters.
  • Investors Research Corp's Sabra Healthcare REIT position peaked at $1K in Q3 2022.
  • 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on Investors Research Corp's 13F filing for Q3 2024, filed 12 Nov 2024.